|
(Health-NewsWire.Net, July 01, 2015 ) According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polymerase chain reaction (PCR). Moreover, the market has seen the advent of hybrid imaging instruments with enhanced accuracy, such as PET/CT and SPECT/CT. These advancements have augmented the growth of the cancer diagnostics market. The instrument-based cancer diagnostics segment accounted for the largest share of the global the cancer diagnostics market, by technology, while breast cancer accounted for the largest share of the cancer diagnostics applications market, in 2014.
Browse 89 market data tables & 37 figures spread through 197 pages and in-depth TOC on " Cancer Diagnostics Market " at http://www.rnrmarketresearch.com/cancer-diagnostics-market-by-technology-elisa-elfa-pcr-ngs-immunohistochemistry-microarray-imaging-mri-ct-pet-ultrasound-mammography-biopsy-application-breast-cancer-lung-cancer-col-market-report.html .
North America accounted for the largest share of the global cancer diagnostics market, followed by Europe, Asia, and the Rest of the World (RoW). In the coming years, the cancer diagnostics market is expected to experience the highest growth rate in the Asian region, with emphasis on India and China. These countries are expected to serve as revenue pockets for companies operating in the cancer diagnostics market.
The global cancer diagnostics market witnesses high competitive intensity as there are several big and many small firms operating in different segments of the market.These companies adopt various strategies (agreements/partnerships/joint ventures/collaborations, new product launches, geographical expansions, and acquisitions) to increase their market shares and establish a strong foothold in the global market.
Order a copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=392074
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies(market penetration, product development/innovation,market development, market diversification, and competitive assessment)for strengthening their market shares.
Priced at $4650 for a single user PDF, a discount on “Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) – Forecast to 2020” research report can be requested at http://www.rnrmarketresearch.com/contacts/discount?rname=392074 .
Related Market Reports:
"Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User – Global Forecast to 2019” research available at http://www.rnrmarketresearch.com/immunoassay-market-technology-enzyme-fluorescent-chemiluminescence-radioimmunoassay-analyzers-reagents-applications-infectious-diseases-cancer-endocrinology-cardiology-end-users-hospi-market-report.html .
Explore more Medical Devices Market Research Reports at http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices .
RnR Market Research
Ritesh Tiwari
+ 18883915441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
|
